Garnet International Ltd.
Garnet International
₹ 0.00
0.00 (0.00)%
NSE
BSE
Finance
Small-cap - With a market cap of ₹1.08 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 14 08 2021 | Quarterly Results |
| 05 10 2021 | Inter alia, to consider and approve : 1. To consider Fund raising and related matters. 2. To consider amalgamation of GVS Chemical Pvt. Ltd. with GIL. 3. To consider any other matter with permission of Chair. |
| 12 10 2021 | General Purpose (Revised) The Board Meeting to be held on 05/10/2021 has been revised to 12/10/2021 |
| 01 11 2021 | Quarterly Results |
| 09 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 25 07 2022 | Quarterly Results |
| 10 10 2022 | Inter alia, to consider and approve :- 1. To approve the Resignation Letter tendered by Ms. Kumkum Shah, Company Secretary & Compliance Officer. 2. To discuss and appoint New Company Secretary & Compliance Officer of the Company. 3. To discuss any other matter with the permission of the Chair. |
| 14 11 2022 | Quarterly Results |
| 11 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 06 06 2023 | Rights Issue & Inter alia, to consider and approve: 1. To discuss on raising funds required for business needs & expansion and allied activities. 2. Any Other Matters with the Permission of the Chair. |
| 14 08 2023 | Quarterly Results |
| 14 11 2023 | Quarterly Results |
| 25 01 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 13 12 2024 | Preferential Issue of shares & Inter alia, to consider and approve : (1) the proposal for raising funds by way of issue of one or more instruments including Equity Shares, Convertible or Non-Convertible Securities of any description or Warrants, through Preferential Issue, Private Placements or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including the approval of the shareholders of the Company. |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 14 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
